These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15199608)

  • 21. Paraneoplastic encephalomyelitis/sensory motor peripheral neuropathy - an autopsy case study.
    Gazic B; Pisem J; Dolenc-Groselj L; Popovic M
    Folia Neuropathol; 2005; 43(2):113-7. PubMed ID: 16012914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of non-small-cell lung carcinoma: PS2 patients' particularities].
    Deppermann KM
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S31-4S34. PubMed ID: 15687991
    [No Abstract]   [Full Text] [Related]  

  • 23. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma.
    Musunuru K; Kesari S
    J Neurooncol; 2008 Nov; 90(2):213-6. PubMed ID: 18618225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adie's pupils in paraneoplastic ganglionopathy with ANNA-1.
    Campellone JV; Hageboutros A
    Clin Neurol Neurosurg; 2006 Oct; 108(7):712-4. PubMed ID: 16139419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.
    Bentea G; Sculier C; Grigoriu B; Meert AP; Durieux V; Berghmans T; Sculier JP
    Lung Cancer; 2017 Apr; 106():83-92. PubMed ID: 28285700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer.
    Monstad SE; Drivsholm L; Storstein A; Aarseth JH; Haugen M; Lang B; Vincent A; Vedeler CA
    J Clin Oncol; 2004 Mar; 22(5):795-800. PubMed ID: 14990634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
    Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
    Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opsoclonus-myoclonus syndrome associated with non-small cell lung cancer.
    Karasaki T; Tanaka M
    Asian Cardiovasc Thorac Ann; 2015 Nov; 23(9):1113-5. PubMed ID: 26038602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.
    Graus F; Vincent A; Pozo-Rosich P; Sabater L; Saiz A; Lang B; Dalmau J
    J Neuroimmunol; 2005 Aug; 165(1-2):166-71. PubMed ID: 15949849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
    Schleusener JT; Tazelaar HD; Jung SH; Cha SS; Cera PJ; Myers JL; Creagan ET; Goldberg RM; Marschke RF
    Cancer; 1996 Apr; 77(7):1284-91. PubMed ID: 8608504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
    Vernino S; Tuite P; Adler CH; Meschia JF; Boeve BF; Boasberg P; Parisi JE; Lennon VA
    Ann Neurol; 2002 May; 51(5):625-30. PubMed ID: 12112110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Hu Antibody-associated Paraneoplastic Neurological Syndrome Showing Peripheral Neuropathy and Atypical Multifocal Brain Lesions.
    Shibata M; Uchida M; Tsukagoshi S; Yamaguchi K; Yamaguchi A; Furuta N; Makioka K; Maeno T; Fujita Y; Kurabayashi M; Ikeda Y
    Intern Med; 2015; 54(23):3057-60. PubMed ID: 26631892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological paraneoplastic syndromes in lung cancer patients.
    Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
    Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invited commentary.
    D'Amico TA
    Ann Thorac Surg; 2011 Feb; 91(2):348-9. PubMed ID: 21256265
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
    Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
    N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
    [No Abstract]   [Full Text] [Related]  

  • 38. Elderly patients with advanced non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
    [No Abstract]   [Full Text] [Related]  

  • 39. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic opsoclonus-myoclonus syndrome as a new and single manifestation of relapsing disease in a patient with small cell lung cancer.
    Nadal E; Bruna J; Ochoa de Olza M; Antonio M; Cardenal F
    J Thorac Oncol; 2011 May; 6(5):968-9. PubMed ID: 21623271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.